1. Evaluation of Akreos AO micro-incision IOL, implantation in 350 eyes :
Danielle DEIDIER, M.D.
Clinique Saint Vincent, Toulon - France
ASCRS 2009
NO FINANCIAL INTEREST IN THIS STUDY

2. Purpose To analyse clinical results of 350 cases:
Implantation of Akreos AO microincision
Incision size = 1.7mm
ASCRS 2009

3. METHODS Prospective study on 350 eyes Single centre, one surgeon
Biaxial surgical technique : two 1.3mm incisions (main one then enlarged to 1.7mm for Akreos MI60 injection).
Stellaris Phacoemulsification system
ASCRS 2009

4. METHODS
Follow-up:
Preoperatively , post-op at 10 days, 1 month, 2 years
OUTCOMES :
BCVA
UCVA
Astigmatism
Endothelial cell count
Stability in capsular bag
Yag laser capsulotomy rate -
ASCRS 2009

5. Akreos MI60 Bausch & Lomb Acrylic Hydrophilic 26% (foldability)
Aspheric: aberration free concept
Anti-PCO features (square edge,
surrounding, angulation ...)
3D stability Haptics
Optic  : 6mm & total  : 11mm
Angulation: 10°
Power: 0 to 30D
ASCRS 2009

6. VISUAL ACUITY 0.4 0.92 0.93 0.96 0.65 0.67 0.7 Visual acuity BCVA
preop 1M 3M
12M
UCVA
MI60
(n=350)
0.4
0.92
0.93
0.96
0.65
0.67
0.7
ASCRS 2009

7. ASTIGMATISM ASTIGMATISM PREOP POSTOP 1M 3M 12M MI60 0.79 0.82 0.8 0.74
(n=350)
0.79
0.82
0.8
0.74
ASCRS 2009

8. ENDOTHELIAL CELL COUNT
PRE-OP
POST-OP
MI60 (n=350)
2263
2126
Which represents a loss of 6.1%
ASCRS 2009

9. RESULTS - Good stability over time with excellent post-op BCVA & UCVA
- Low level of induced astigmatism & no change
in axis
- Low endothelial cell loss
- 15 capsulotomy (PCO) since beginning of study (sept 06)
- 2 Rhexis phimosis
- 8 Fibrosis of posterior capsular bag surface without loss of visual acuity

10. CONCLUSION
After two years working with Akreos AO micro-incision MI60, clinical outcomes are excellent and post-operative complications rate is very low.
We succeed in our challenge to implant an aspheric microincision IOL through 1.7mm without induced astigmatism, in a reproducible and safe manner.
ASCRS 2009